image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5326
-9.44 %
$ 44.1 M
Market Cap
-0.45
P/E
BALANCE SHEET
220 M ASSETS
6.23%
33.6 M LIABILITIES
-9.46%
187 M EQUITY
9.66%
BALANCE SHEET DECOMPOSITION
Balance Sheet Adicet Bio, Inc.
image
Current Assets 180 M
Cash & Short-Term Investments 176 M
Receivables 0
Other Current Assets 3.83 M
Non-Current Assets 40.1 M
Long-Term Investments 0
PP&E 36.8 M
Other Non-Current Assets 3.33 M
80.06 %16.69 %Total Assets$220.2m
Current Liabilities 19.4 M
Accounts Payable 4.83 M
Short-Term Debt 3.13 M
Other Current Liabilities 11.4 M
Non-Current Liabilities 14.2 M
Long-Term Debt 0
Other Non-Current Liabilities 14.2 M
14.37 %9.32 %34.01 %42.30 %Total Liabilities$33.6m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012 Jun-2011 Jun-2010 Jun-2009 Jun-2008
ASSETS
Cash & Cash Equivalents 56.5 159.7 257.7 277.5 84.3 10.6 7.0 53.3 66.8 34.0 42.9 33.2 24.9 28.7 30.9 57.8 46.5
Short Term Investments 119.8 0 0 0 10.3 51.8 101.0 2.0 0.9 3.4 0.7 2.1 1.5 0.9 0.3 0.5 0.5
Receivables 0 0 0.4 0.2 0 0.9 0 0 167.6 161.5 122.7 90.1 74.7 83.7 74.7 0 0
Inventory 0 0 2.6 4.7 (3.1) 0.7 0 136.4 98.1 95.6 100.7 83.8 84.7 77.4 74.9 54.4 71.1
Other Current Assets 3.8 2.6 2.9 4.7 5.6 0.9 0.9 0.9 19.2 15.8 9.3 9.0 6.2 7.8 14.8 58.9 75.6
Total Current Assets 180.1 162.3 261.0 282.4 94.6 64.2 109.5 54.2 352.7 310.3 276.4 218.3 192.0 198.6 195.6 171.6 193.8
PP&E 36.8 44.2 49.0 35.0 25.9 2.1 0.3 39 K 10.0 10.5 11.6 11.4 11.7 12.1 6.9 4.2 4.3
Intangible Assets 0 0 0 0 1.2 0 0 285.1 79.1 79.0 88.0 40.8 45.3 50.7 12.4 11.5 5.4
Goodwill 0 0 19.5 19.5 20.1 0 0 237.0 67.9 67.9 66.5 33.5 33.5 33.6 1.7 1.9 2.0
Long Term Investments 0 0 0 0.1 4.5 10.6 84 K (541.5) 0 0 0 0 0 0 0 0 0
Other Long Term Assets 3.3 0.8 1.2 2.0 12.1 4.7 1 0.9 13.1 12.2 14.0 11.3 12.1 0 0 0 0
Other Assets 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0
Total Assets 220.2 207.3 330.7 338.9 153.8 81.6 109.9 55.2 540.8 489.8 468.0 323.4 299.3 295.0 216.6 189.3 205.5
LIABILITIES
Accounts Payable 4.8 2.6 4.4 3.3 1.6 1.1 0.5 1.5 46.0 55.0 48.7 39.2 42.0 44.6 40.0 25.1 43.5
Short Term Debt 3.1 3.2 5.0 3.1 2.4 0 0 14.5 0.2 10.2 8.3 11.7 6.7 0 0 0 0
Other Current Liabilities 11.4 13.4 10.3 5.1 4.5 2.8 5.2 (10.8) 47.3 57.8 54.6 34.3 24.1 37.8 32.8 20.2 19.8
Total Current Liabilities 19.4 19.3 19.7 16.3 14.0 14.9 5.7 5.5 98.9 125.0 118.5 89.9 73.6 83.2 74.6 46.9 65.0
Long Term Debt 0 17.7 18.5 19.4 20.4 0 3.1 339.2 118.6 100.0 97.2 20.4 39.1 6.2 33.6 20.7 19.9
Deferred Tax Income 0 0 0 0 0.1 (114.1) 0 7.3 9.1 66 K 6 K 6 K 8 K 0 0 0 0
Other Liabilities 14.2 0.1 0.1 0.1 1.0 116.2 (3.1) (346.5) 6.3 7.5 11.6 13.4 12.9 0 0 0 0
Total Liabilities 33.6 37.1 38.4 35.8 44.0 142.0 5.7 5.5 236.3 235.6 234.4 128.8 131.3 150.8 92.2 63.9 81.8
EQUITY
Common Stock 8 K 4 K 4 K 4 K 2 K 4 K 3 K 1 K 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Retained Earnings (497.9) (380.8) (238.1) (168.3) (106.3) (69.6) (71.4) (33.8) 194.8 167.2 140.8 118.6 102.3 90.7 87.0 85.5 81.8
Other Accumulative Comprehensive Income/Loss 16 K 0 0 (338.9) 24 K 23 K 41 K (5.1) (6.3) (7.1) 5.4 2.9 1.3 7.7 1.0 7.5 13.1
Total Equity 186.6 170.2 (238.1) (168.3) (106.3) (60.4) 104.2 49.7 304.4 254.2 233.6 194.6 168.0 160.8 139.6 141.6 140.4
Total Liabilities and Equity 220.2 207.3 (199.8) (132.5) 153.8 81.6 109.9 55.2 540.8 489.8 468.0 323.4 299.3 295.0 216.6 189.3 205.5
SHARES OUTSTANDING
Common Shares Outstanding 87.9 43.0 41.1 31.0 7.3 18.6 29.8 26.8 28.0 24.5 23.7 23.7 23.3 22.7 21.9 21.4 21.3